Criteria for the translation of radiomics into clinically useful tests

Erich P Huang*, James P B O'Connor, Lisa M McShane, Maryellen L Giger, Philippe Lambin, Paul E Kinahan, Eliot L Siegel, Lalitha K Shankar

*Corresponding author for this work

Research output: Contribution to journal(Systematic) Review article peer-review

19 Downloads (Pure)

Abstract

Computer-extracted tumour characteristics have been incorporated into medical imaging computer-aided diagnosis (CAD) algorithms for decades. With the advent of radiomics, an extension of CAD involving high-throughput computer-extracted quantitative characterization of healthy or pathological structures and processes as captured by medical imaging, interest in such computer-extracted measurements has increased substantially. However, despite the thousands of radiomic studies, the number of settings in which radiomics has been successfully translated into a clinically useful tool or has obtained FDA clearance is comparatively small. This relative dearth might be attributable to factors such as the varying imaging and radiomic feature extraction protocols used from study to study, the numerous potential pitfalls in the analysis of radiomic data, and the lack of studies showing that acting upon a radiomic-based tool leads to a favourable benefit-risk balance for the patient. Several guidelines on specific aspects of radiomic data acquisition and analysis are already available, although a similar roadmap for the overall process of translating radiomics into tools that can be used in clinical care is needed. Herein, we provide 16 criteria for the effective execution of this process in the hopes that they will guide the development of more clinically useful radiomic tests in the future.

Original languageEnglish
Pages (from-to)69-82
Number of pages14
JournalNature Reviews Clinical Oncology
Volume20
Issue number2
Early online date28 Nov 2022
DOIs
Publication statusPublished - Feb 2023

Cite this